Skip to main content
Fig. 3 | Chinese Medicine

Fig. 3

From: Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro

Fig. 3

Effects of LS (2, 1 and 0.5 μg/mL) on the mRNA expression levels of inflammatory mediators (IL-1α (A), IL-6 (B), CCL-5 (C) and IP-10 (D)) in the G/478K.V1/ B.1.617.2 strain-infected cells. Data were presented as the mean ± SD obtained from three separate experiments. *P < 0.05; **P < 0.01; ***P < 0.001, compared with the G/478K.V1/ B.1.617.2 strain-infected cells

Back to article page

Chinese Medicine

ISSN: 1749-8546

Contact us